Biologics and small Drug Molecules
| Small Molecule Drug | Biological Drug |
| AR1001 | Lecanemab- anti amyloid antibody |
| Buntanetap | Semaglutide |
| Mastinib | Gonadorelin |
| Metformin | Donanemab – anti amyloid antibody |
| Niolimib | E2814 |
| PMO12 – herbal formula | Gantenerumab – anti amyloid antibody |
| Simufilam ( failed phase 3 studies) | Terlomotide is a fragment derived from the human telomerase reverse transcriptase (hTERT) enzyme, specifically a 16–amino acid sequence (hTERT 611–626). |
| Tricaprilin | Remternetug is an anti-amyloid antibody developed by Eli Lilly |
| Valiltramiprosate – prevents oligomerization of Amyloid Beta | Solanezumab selectively targets and binds to soluble monomeric forms of amyloid-beta (Aβ) peptides in the brain – from Eli Lilly |
| Wujia Yitzhi |
small Extracellular vesicles with exerkines, miRNA, AAV vectors, and circRNA
Stem Cells – Various Types
Genetically engineered microglia with trans skull brain injection
Intracisternal CSF injection of AAV vectors with ApoE2 christchurch and anti APOE4 miRNA
KCTD20 gene inactivation in glutamate excitatory neurons
